• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Human Hepatitis B Immunoglobulin
    2 Drugs classified under this active ingredient

    All the Active Ingredient Drugs

    Hepatect CP
    partial basket chart
    Hepatect CP

    Human Hepatitis B Immunoglobulin 50 IU/ml.
    AMPS: 2 ml.
    VIALS: 10 ml, 40 ml. Aft. infect: 0.12 ml -
    0.20 ml (6 IU - 10 IU)/kg bdy. wt. Proph.
    (in high risk): Inject 0.14 ml (7 IU)/kg
    bdy. wt. aft. screen. for HbsAg and
    anti-HBs. Repeat at 2 mth. intervals.
    See lit. Proph. in newborns og HBsantigen
    positive mothers: 0.4 ml (20
    IU)/kg bdy. wt. immed. aft. birth. See
    Proph. against hepatit. B in adults and
    child over 2 yrs. who have not been
    vaccinat. against hepatit. B (incl. persons
    whose vaccinat. is incomplete or missing),
    at risk by accident. contact e.g. accident.
    needle stick or direct mucous membrane
    contact when admin. of I.M. hepatit.
    immunoglob. is not possible. To be admin.
    with hepatit. B vaccine. Immunoproph.
    hepatit. B in newborn of hepatit. B virus
    carrier mother.
    C/I: Hypersens. to homologous

    Omri-Hep-B 5% IV
    Omrix Biopharmaceuticals
    partial basket chart
    Omri-Hep-B 5% IV

    Human Hepatitis B Immunoglobulin 50 IU/ml.
    I.V. VIAL: 1 x 100 ml x 50 IU/ml anti
    HBsAg. 10,000 IU in anhepatic stage
    (OLT foll. by 10,000 IU dly for 1st 5-7
    days) aft. transplant. See lit.
    Passive. immunizant. prevent hepatit. B
    re-infect. aft. liver transplant. See lit.
    C/I: Anaphylact. or severe system.
    response to I.M./I.V. immunoglob. preps.
    Not to be given with antibodies
    to IgA or selective IgA defic.